{"gene":"KCNK17","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2004,"finding":"TALK-2 (K2P17.1) channels expressed in Xenopus oocytes are strongly and specifically activated by nitric oxide (via SNP+DTT), superoxide anion (via xanthine/xanthine oxidase), and singlet oxygen (via rose bengal photoactivation or chloramine T), identifying these reactive species as direct modulators of channel activity.","method":"Two-electrode voltage clamp electrophysiology in Xenopus oocytes with pharmacological application of ROS/RNS donors","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay in heterologous expression system with multiple orthogonal stimuli and controls","pmids":["15513946"],"is_preprint":false},{"year":2014,"finding":"A gain-of-function missense mutation G88R in the first extracellular pore loop of TASK-4 (KCNK17) generates threefold increased currents without altering surface expression, indicating enhanced conductivity; the gain-of-function is conferred in a dominant-active manner upon co-expression with wild-type channels, and overexpression of G88R hyperpolarizes and slows the upstroke velocity of spontaneously beating HL-1 cells.","method":"Whole-exome sequencing to identify mutation; two-electrode voltage clamp electrophysiology in Xenopus oocytes for current measurements; surface expression assay; action potential recordings in HL-1 cardiomyocytes","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with electrophysiology, surface expression, and cellular functional assay","pmids":["24972929"],"is_preprint":false},{"year":2017,"finding":"TALK-2 (K2P17.1) forms heterodimers with TASK-1 (from a different K2P subfamily) in a pancreatic cell line and in HEK293 cells; the heterodimer displays unique hybrid sensitivities to extracellular pH and halothane compared to either homodimer, and TASK-1 currents are attenuated by a dominant-negative form of TALK-2.","method":"Single-molecule TIRF imaging, bimolecular fluorescence complementation (BiFC), FRET, and whole-cell patch-clamp electrophysiology","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (TIRF, BiFC, FRET, patch-clamp) in a single study","pmids":["29016681"],"is_preprint":false},{"year":2018,"finding":"Human K2P17.1 (TASK-4/TALK-2) channels are activated by antiarrhythmic drugs propafenone, quinidine, mexiletine, propranolol, and metoprolol, and inhibited by amiodarone, sotalol, verapamil, and ranolazine, as measured by two-electrode voltage clamp in Xenopus oocytes and confirmed by whole-cell patch clamp in CHO cells; propafenone activation is fast in onset and does not alter current-voltage relationships.","method":"Two-electrode voltage clamp in Xenopus oocytes and whole-cell patch clamp in CHO cells","journal":"Naunyn-Schmiedeberg's archives of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — in vitro electrophysiology replicated in two heterologous expression systems","pmids":["30008082"],"is_preprint":false},{"year":2018,"finding":"Zebrafish K2P17.1 conducts K+-selective currents with open rectification and is inhibited by barium, similar to human K2P17.1; however, unlike the human channel, zebrafish K2P17.1 is insensitive to extracellular alkalization, attributable to the absence of a lysine residue required for pH sensing in the human ortholog.","method":"Two-electrode voltage clamp electrophysiology in Xenopus oocytes; sequence alignment identifying the pH-sensing lysine residue","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 — functional electrophysiology with mechanistic residue identification, but single study","pmids":["29753045"],"is_preprint":false},{"year":2024,"finding":"K2P17.1 (TALK-2/TASK-4) possesses a cytoplasmic lower gate in addition to the selectivity filter (SF) gate; stimuli targeting the SF gate (extracellular pH, Rb+ permeation, membrane depolarization) also open the lower gate, and opening of the lower gate reciprocally reduces the energy required to open the SF gate via voltage-driven ion binding, demonstrating positive allosteric coupling between the two gates.","method":"Electrophysiology combined with fast cysteine modification assay (MTSET accessibility), pharmacological and lipid modulation, and mutagenesis of pore cysteine residues","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — reconstitution-level functional assay (cysteine accessibility) combined with mutagenesis and pharmacology, establishing bidirectional gate coupling","pmids":["39215031"],"is_preprint":false},{"year":2026,"finding":"TALK-2 (KCNK17) localizes to both the plasma membrane and the ER membrane of human beta cells and forms functional K+ channels on the ER membrane; ER-localized TALK-2 increases the electrical driving force for Ca2+ leak from the ER, accelerating Ca2+ER release, reducing ER Ca2+ stores, and elevating basal cytoplasmic Ca2+, thereby promoting basal insulin secretion while limiting glucose-stimulated insulin secretion (GSIS).","method":"Immunofluorescence and TALK-2-GFP co-localization with ER markers; measurement of cytoplasmic and ER Ca2+ (Ca2+C, Ca2+ER); ER membrane potential sensing (ASAP3ER); K+ current recordings; insulin secretion assays in inducible cell line and adenoviral shRNA knockdown in primary human beta cells and pseudoislets","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (localization, electrophysiology, Ca2+ imaging, functional secretion assay) in both cell line and primary human cells","pmids":["41739147"],"is_preprint":false}],"current_model":"KCNK17-encoded K2P17.1 (TASK-4/TALK-2) is a two-gate background K+ channel that is activated by alkaline pH (via a pore-loop lysine), reactive oxygen/nitrogen species, and drugs such as propafenone, whose selectivity filter gate and cytoplasmic lower gate are positively coupled; it forms heterodimers with TASK-1, localizes to both the plasma and ER membranes of beta cells where it drives ER Ca2+ leak to modulate insulin secretion, and gain-of-function mutations (e.g., G88R) dominant-actively hyperpolarize cardiac conduction cells, linking it to arrhythmia."},"narrative":{"teleology":[{"year":2004,"claim":"Identifying the stimuli that gate K2P17.1 was essential; demonstrating that nitric oxide, superoxide, and singlet oxygen each robustly activate the channel established ROS/RNS as direct modulators, distinguishing TALK-2 from other K2P family members.","evidence":"Two-electrode voltage clamp in Xenopus oocytes with multiple ROS/RNS donors and appropriate controls","pmids":["15513946"],"confidence":"High","gaps":["Molecular target residue(s) for ROS/RNS modification not identified","Physiological relevance of ROS activation not tested in native tissues"]},{"year":2014,"claim":"Linking a specific mutation to disease required showing that G88R increases K⁺ current threefold without altering surface expression and acts dominant-actively, thereby hyperpolarizing cardiomyocytes — establishing a gain-of-function mechanism for arrhythmia.","evidence":"Whole-exome sequencing, two-electrode voltage clamp in oocytes, surface expression assay, and action potential recordings in HL-1 cardiomyocytes","pmids":["24972929"],"confidence":"High","gaps":["No in vivo animal model to confirm arrhythmogenicity","Structural basis of G88R-mediated conductance increase unknown"]},{"year":2017,"claim":"Whether K2P channels from different subfamilies can heterodimerize was unresolved; demonstrating that TALK-2 and TASK-1 form functional heterodimers with hybrid pharmacological properties expanded the combinatorial diversity of background K⁺ currents.","evidence":"Single-molecule TIRF, BiFC, FRET, and whole-cell patch clamp in pancreatic cell line and HEK293 cells","pmids":["29016681"],"confidence":"High","gaps":["Stoichiometry and structure of the heterodimer not determined","Native tissue abundance of heterodimer versus homodimer not quantified"]},{"year":2018,"claim":"The pharmacological profile of K2P17.1 was largely uncharacterized; showing activation by propafenone, quinidine, and mexiletine and inhibition by amiodarone and verapamil revealed that common antiarrhythmic drugs directly modulate the channel, with potential clinical implications for patients carrying gain-of-function variants.","evidence":"Two-electrode voltage clamp in oocytes and whole-cell patch clamp in CHO cells","pmids":["30008082"],"confidence":"High","gaps":["Drug binding sites on the channel not mapped","In vivo relevance of drug-channel interactions at therapeutic concentrations not established"]},{"year":2018,"claim":"The molecular basis of alkaline pH activation was clarified by cross-species comparison: zebrafish K2P17.1 lacks the pore-loop lysine present in the human channel and is pH-insensitive, pinpointing this residue as the pH sensor.","evidence":"Electrophysiology in oocytes and sequence alignment identifying critical lysine","pmids":["29753045"],"confidence":"Medium","gaps":["Lysine mutant in human channel not directly tested in this study","Mechanism by which lysine protonation state alters conductance not elucidated"]},{"year":2024,"claim":"Whether K2P17.1 possesses a functional lower gate was unknown; demonstrating a cytoplasmic gate that is positively coupled to the selectivity filter gate — with each gate's opening facilitating the other — revealed a dual-gate allosteric mechanism governing channel activity.","evidence":"Electrophysiology with fast cysteine modification (MTSET accessibility), pharmacological and lipid modulation, and pore-cysteine mutagenesis","pmids":["39215031"],"confidence":"High","gaps":["Structural basis of gate coupling not resolved at atomic level","Whether heterodimeric channels with TASK-1 share the same coupling mechanism is unknown"]},{"year":2026,"claim":"K2P17.1 was assumed to function only at the plasma membrane; showing that it also resides on the ER membrane where it drives K⁺ flux that enhances ER Ca²⁺ leak, thereby elevating basal Ca²⁺ and promoting basal insulin secretion while dampening glucose-stimulated secretion, established a novel intracellular function.","evidence":"Co-localization with ER markers, ER membrane potential sensing, cytoplasmic and ER Ca²⁺ measurements, and insulin secretion assays in an inducible cell line and primary human beta cells with shRNA knockdown","pmids":["41739147"],"confidence":"High","gaps":["How K2P17.1 is trafficked to and retained in the ER membrane is unknown","Whether ER-localized K2P17.1 function is relevant in non-beta-cell types is untested","Relative contribution of ER versus plasma membrane channels to beta-cell physiology not quantified"]},{"year":null,"claim":"A high-resolution structure of K2P17.1 — either as homodimer or TASK-1 heterodimer — is lacking, leaving the structural basis of dual-gate coupling, ROS sensing, pH sensing, and drug modulation unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure available","ROS/RNS-sensing residues not identified by mutagenesis","In vivo cardiac phenotype of G88R not modeled in animals"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,3,4,5,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6]}],"complexes":[],"partners":["KCNK3"],"other_free_text":[]},"mechanistic_narrative":"KCNK17 encodes K2P17.1 (TALK-2/TASK-4), a two-pore-domain background potassium channel that sets resting membrane potential and is gated by alkaline extracellular pH (via a pore-loop lysine), reactive oxygen and nitrogen species, and pharmacological agents including propafenone [PMID:15513946, PMID:29753045, PMID:30008082]. The channel operates through two positively coupled gates — a selectivity filter gate and a cytoplasmic lower gate — whose allosteric linkage ensures that stimuli opening one gate facilitate opening of the other [PMID:39215031]. K2P17.1 heterodimerizes with TASK-1 to produce channels with hybrid pH and anesthetic sensitivities, and localizes to both the plasma membrane and the endoplasmic reticulum membrane of pancreatic beta cells, where ER-resident channels drive Ca²⁺ leak from ER stores to promote basal insulin secretion while limiting glucose-stimulated secretion [PMID:29016681, PMID:41739147]. A gain-of-function G88R mutation confers dominant-active enhancement of K⁺ current, hyperpolarizes and slows action potential upstroke in cardiomyocytes, and is linked to cardiac arrhythmia [PMID:24972929]."},"prefetch_data":{"uniprot":{"accession":"Q96T54","full_name":"Potassium channel subfamily K member 17","aliases":["2P domain potassium channel Talk-2","Acid-sensitive potassium channel protein TASK-4","TWIK-related acid-sensitive K(+) channel 4","TWIK-related alkaline pH-activated K(+) channel 2","TALK-2"],"length_aa":332,"mass_kda":36.9,"function":"K(+) channel that conducts voltage-dependent outward rectifying currents upon membrane depolarization. Voltage sensing is coupled to K(+) electrochemical gradient in an 'ion flux gating' mode where outward but not inward ion flow opens the gate (PubMed:11248242, PubMed:11263999, PubMed:26919430, PubMed:36063992). Homo- and heterodimerizes to form functional channels with distinct regulatory and gating properties (PubMed:36063992). Present in the cardiac conduction system where it may regulate action potential duration and beating frequency of cardiac myocytes (PubMed:24972929). Permeable to other monovalent cations such as Rb(+) and Cs(+) (By similarity) (PubMed:26919430)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96T54/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNK17","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNK17","total_profiled":1310},"omim":[{"mim_id":"607370","title":"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17; KCNK17","url":"https://www.omim.org/entry/607370"},{"mim_id":"607369","title":"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16; KCNK16","url":"https://www.omim.org/entry/607369"},{"mim_id":"603220","title":"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3","url":"https://www.omim.org/entry/603220"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":26.6}],"url":"https://www.proteinatlas.org/search/KCNK17"},"hgnc":{"alias_symbol":["K2p17.1","TALK-2","TALK2","TASK4","TASK-4"],"prev_symbol":[]},"alphafold":{"accession":"Q96T54","domains":[{"cath_id":"1.10.287.70","chopping":"114-267","consensus_level":"medium","plddt":89.6795,"start":114,"end":267}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96T54","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96T54-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96T54-F1-predicted_aligned_error_v6.png","plddt_mean":76.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNK17","jax_strain_url":"https://www.jax.org/strain/search?query=KCNK17"},"sequence":{"accession":"Q96T54","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96T54.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96T54/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96T54"}},"corpus_meta":[{"pmid":"15513946","id":"PMC_15513946","title":"Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15513946","citation_count":65,"is_preprint":false},{"pmid":"24972929","id":"PMC_24972929","title":"Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder.","date":"2014","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24972929","citation_count":59,"is_preprint":false},{"pmid":"19647252","id":"PMC_19647252","title":"KCNK17 genetic variants in ischemic stroke.","date":"2009","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/19647252","citation_count":26,"is_preprint":false},{"pmid":"23542407","id":"PMC_23542407","title":"Mechanisms of pelvic organ cross-talk: 2. Impact of colorectal distention on afferent nerve activity of the rat bladder.","date":"2013","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/23542407","citation_count":19,"is_preprint":false},{"pmid":"29016681","id":"PMC_29016681","title":"Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29016681","citation_count":14,"is_preprint":false},{"pmid":"25179130","id":"PMC_25179130","title":"Association of variants in KCNK17 gene with ischemic stroke and cerebral hemorrhage in a Chinese population.","date":"2014","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/25179130","citation_count":11,"is_preprint":false},{"pmid":"30008082","id":"PMC_30008082","title":"Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.","date":"2018","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30008082","citation_count":9,"is_preprint":false},{"pmid":"19701402","id":"PMC_19701402","title":"Low-cross-talk 2 x 2 optical switch.","date":"1981","source":"Optics letters","url":"https://pubmed.ncbi.nlm.nih.gov/19701402","citation_count":7,"is_preprint":false},{"pmid":"39215031","id":"PMC_39215031","title":"Ion occupancy of the selectivity filter controls opening of a cytoplasmic gate in the K2P channel TALK-2.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39215031","citation_count":6,"is_preprint":false},{"pmid":"29753045","id":"PMC_29753045","title":"Identification and functional characterization of zebrafish K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.","date":"2018","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29753045","citation_count":4,"is_preprint":false},{"pmid":"41782661","id":"PMC_41782661","title":"Cardiac Manifestations of KCNK17 Mutations and/or Polymorphisms: A Systematic Review.","date":"2026","source":"Health science reports","url":"https://pubmed.ncbi.nlm.nih.gov/41782661","citation_count":0,"is_preprint":false},{"pmid":"20155449","id":"PMC_20155449","title":"Identification of common variants within KCNK17 in Chinese Han population.","date":"2010","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/20155449","citation_count":0,"is_preprint":false},{"pmid":"41739147","id":"PMC_41739147","title":"The diabetes-associated K+ channel TALK-2 controls human beta cell endoplasmic reticulum Ca2+ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion.","date":"2026","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/41739147","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.25.25327632","title":"Methylome and transcriptome functional analysis identifies key biomarkers in ketamine’s sustained therapeutic effect on PTSD","date":"2025-05-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.25.25327632","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.05.652166","title":"Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in rheumatoid arthritis patients","date":"2025-05-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.05.652166","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10041,"output_tokens":1998,"usd":0.030047},"stage2":{"model":"claude-opus-4-6","input_tokens":5259,"output_tokens":2061,"usd":0.11673},"total_usd":0.146777,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"TALK-2 (K2P17.1) channels expressed in Xenopus oocytes are strongly and specifically activated by nitric oxide (via SNP+DTT), superoxide anion (via xanthine/xanthine oxidase), and singlet oxygen (via rose bengal photoactivation or chloramine T), identifying these reactive species as direct modulators of channel activity.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology in Xenopus oocytes with pharmacological application of ROS/RNS donors\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay in heterologous expression system with multiple orthogonal stimuli and controls\",\n      \"pmids\": [\"15513946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A gain-of-function missense mutation G88R in the first extracellular pore loop of TASK-4 (KCNK17) generates threefold increased currents without altering surface expression, indicating enhanced conductivity; the gain-of-function is conferred in a dominant-active manner upon co-expression with wild-type channels, and overexpression of G88R hyperpolarizes and slows the upstroke velocity of spontaneously beating HL-1 cells.\",\n      \"method\": \"Whole-exome sequencing to identify mutation; two-electrode voltage clamp electrophysiology in Xenopus oocytes for current measurements; surface expression assay; action potential recordings in HL-1 cardiomyocytes\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with electrophysiology, surface expression, and cellular functional assay\",\n      \"pmids\": [\"24972929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TALK-2 (K2P17.1) forms heterodimers with TASK-1 (from a different K2P subfamily) in a pancreatic cell line and in HEK293 cells; the heterodimer displays unique hybrid sensitivities to extracellular pH and halothane compared to either homodimer, and TASK-1 currents are attenuated by a dominant-negative form of TALK-2.\",\n      \"method\": \"Single-molecule TIRF imaging, bimolecular fluorescence complementation (BiFC), FRET, and whole-cell patch-clamp electrophysiology\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (TIRF, BiFC, FRET, patch-clamp) in a single study\",\n      \"pmids\": [\"29016681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human K2P17.1 (TASK-4/TALK-2) channels are activated by antiarrhythmic drugs propafenone, quinidine, mexiletine, propranolol, and metoprolol, and inhibited by amiodarone, sotalol, verapamil, and ranolazine, as measured by two-electrode voltage clamp in Xenopus oocytes and confirmed by whole-cell patch clamp in CHO cells; propafenone activation is fast in onset and does not alter current-voltage relationships.\",\n      \"method\": \"Two-electrode voltage clamp in Xenopus oocytes and whole-cell patch clamp in CHO cells\",\n      \"journal\": \"Naunyn-Schmiedeberg's archives of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology replicated in two heterologous expression systems\",\n      \"pmids\": [\"30008082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Zebrafish K2P17.1 conducts K+-selective currents with open rectification and is inhibited by barium, similar to human K2P17.1; however, unlike the human channel, zebrafish K2P17.1 is insensitive to extracellular alkalization, attributable to the absence of a lysine residue required for pH sensing in the human ortholog.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology in Xenopus oocytes; sequence alignment identifying the pH-sensing lysine residue\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — functional electrophysiology with mechanistic residue identification, but single study\",\n      \"pmids\": [\"29753045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"K2P17.1 (TALK-2/TASK-4) possesses a cytoplasmic lower gate in addition to the selectivity filter (SF) gate; stimuli targeting the SF gate (extracellular pH, Rb+ permeation, membrane depolarization) also open the lower gate, and opening of the lower gate reciprocally reduces the energy required to open the SF gate via voltage-driven ion binding, demonstrating positive allosteric coupling between the two gates.\",\n      \"method\": \"Electrophysiology combined with fast cysteine modification assay (MTSET accessibility), pharmacological and lipid modulation, and mutagenesis of pore cysteine residues\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution-level functional assay (cysteine accessibility) combined with mutagenesis and pharmacology, establishing bidirectional gate coupling\",\n      \"pmids\": [\"39215031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TALK-2 (KCNK17) localizes to both the plasma membrane and the ER membrane of human beta cells and forms functional K+ channels on the ER membrane; ER-localized TALK-2 increases the electrical driving force for Ca2+ leak from the ER, accelerating Ca2+ER release, reducing ER Ca2+ stores, and elevating basal cytoplasmic Ca2+, thereby promoting basal insulin secretion while limiting glucose-stimulated insulin secretion (GSIS).\",\n      \"method\": \"Immunofluorescence and TALK-2-GFP co-localization with ER markers; measurement of cytoplasmic and ER Ca2+ (Ca2+C, Ca2+ER); ER membrane potential sensing (ASAP3ER); K+ current recordings; insulin secretion assays in inducible cell line and adenoviral shRNA knockdown in primary human beta cells and pseudoislets\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (localization, electrophysiology, Ca2+ imaging, functional secretion assay) in both cell line and primary human cells\",\n      \"pmids\": [\"41739147\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNK17-encoded K2P17.1 (TASK-4/TALK-2) is a two-gate background K+ channel that is activated by alkaline pH (via a pore-loop lysine), reactive oxygen/nitrogen species, and drugs such as propafenone, whose selectivity filter gate and cytoplasmic lower gate are positively coupled; it forms heterodimers with TASK-1, localizes to both the plasma and ER membranes of beta cells where it drives ER Ca2+ leak to modulate insulin secretion, and gain-of-function mutations (e.g., G88R) dominant-actively hyperpolarize cardiac conduction cells, linking it to arrhythmia.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNK17 encodes K2P17.1 (TALK-2/TASK-4), a two-pore-domain background potassium channel that sets resting membrane potential and is gated by alkaline extracellular pH (via a pore-loop lysine), reactive oxygen and nitrogen species, and pharmacological agents including propafenone [PMID:15513946, PMID:29753045, PMID:30008082]. The channel operates through two positively coupled gates — a selectivity filter gate and a cytoplasmic lower gate — whose allosteric linkage ensures that stimuli opening one gate facilitate opening of the other [PMID:39215031]. K2P17.1 heterodimerizes with TASK-1 to produce channels with hybrid pH and anesthetic sensitivities, and localizes to both the plasma membrane and the endoplasmic reticulum membrane of pancreatic beta cells, where ER-resident channels drive Ca²⁺ leak from ER stores to promote basal insulin secretion while limiting glucose-stimulated secretion [PMID:29016681, PMID:41739147]. A gain-of-function G88R mutation confers dominant-active enhancement of K⁺ current, hyperpolarizes and slows action potential upstroke in cardiomyocytes, and is linked to cardiac arrhythmia [PMID:24972929].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying the stimuli that gate K2P17.1 was essential; demonstrating that nitric oxide, superoxide, and singlet oxygen each robustly activate the channel established ROS/RNS as direct modulators, distinguishing TALK-2 from other K2P family members.\",\n      \"evidence\": \"Two-electrode voltage clamp in Xenopus oocytes with multiple ROS/RNS donors and appropriate controls\",\n      \"pmids\": [\"15513946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target residue(s) for ROS/RNS modification not identified\", \"Physiological relevance of ROS activation not tested in native tissues\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linking a specific mutation to disease required showing that G88R increases K⁺ current threefold without altering surface expression and acts dominant-actively, thereby hyperpolarizing cardiomyocytes — establishing a gain-of-function mechanism for arrhythmia.\",\n      \"evidence\": \"Whole-exome sequencing, two-electrode voltage clamp in oocytes, surface expression assay, and action potential recordings in HL-1 cardiomyocytes\",\n      \"pmids\": [\"24972929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vivo animal model to confirm arrhythmogenicity\", \"Structural basis of G88R-mediated conductance increase unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether K2P channels from different subfamilies can heterodimerize was unresolved; demonstrating that TALK-2 and TASK-1 form functional heterodimers with hybrid pharmacological properties expanded the combinatorial diversity of background K⁺ currents.\",\n      \"evidence\": \"Single-molecule TIRF, BiFC, FRET, and whole-cell patch clamp in pancreatic cell line and HEK293 cells\",\n      \"pmids\": [\"29016681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the heterodimer not determined\", \"Native tissue abundance of heterodimer versus homodimer not quantified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The pharmacological profile of K2P17.1 was largely uncharacterized; showing activation by propafenone, quinidine, and mexiletine and inhibition by amiodarone and verapamil revealed that common antiarrhythmic drugs directly modulate the channel, with potential clinical implications for patients carrying gain-of-function variants.\",\n      \"evidence\": \"Two-electrode voltage clamp in oocytes and whole-cell patch clamp in CHO cells\",\n      \"pmids\": [\"30008082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Drug binding sites on the channel not mapped\", \"In vivo relevance of drug-channel interactions at therapeutic concentrations not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The molecular basis of alkaline pH activation was clarified by cross-species comparison: zebrafish K2P17.1 lacks the pore-loop lysine present in the human channel and is pH-insensitive, pinpointing this residue as the pH sensor.\",\n      \"evidence\": \"Electrophysiology in oocytes and sequence alignment identifying critical lysine\",\n      \"pmids\": [\"29753045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Lysine mutant in human channel not directly tested in this study\", \"Mechanism by which lysine protonation state alters conductance not elucidated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Whether K2P17.1 possesses a functional lower gate was unknown; demonstrating a cytoplasmic gate that is positively coupled to the selectivity filter gate — with each gate's opening facilitating the other — revealed a dual-gate allosteric mechanism governing channel activity.\",\n      \"evidence\": \"Electrophysiology with fast cysteine modification (MTSET accessibility), pharmacological and lipid modulation, and pore-cysteine mutagenesis\",\n      \"pmids\": [\"39215031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of gate coupling not resolved at atomic level\", \"Whether heterodimeric channels with TASK-1 share the same coupling mechanism is unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"K2P17.1 was assumed to function only at the plasma membrane; showing that it also resides on the ER membrane where it drives K⁺ flux that enhances ER Ca²⁺ leak, thereby elevating basal Ca²⁺ and promoting basal insulin secretion while dampening glucose-stimulated secretion, established a novel intracellular function.\",\n      \"evidence\": \"Co-localization with ER markers, ER membrane potential sensing, cytoplasmic and ER Ca²⁺ measurements, and insulin secretion assays in an inducible cell line and primary human beta cells with shRNA knockdown\",\n      \"pmids\": [\"41739147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How K2P17.1 is trafficked to and retained in the ER membrane is unknown\", \"Whether ER-localized K2P17.1 function is relevant in non-beta-cell types is untested\", \"Relative contribution of ER versus plasma membrane channels to beta-cell physiology not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of K2P17.1 — either as homodimer or TASK-1 heterodimer — is lacking, leaving the structural basis of dual-gate coupling, ROS sensing, pH sensing, and drug modulation unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure available\", \"ROS/RNS-sensing residues not identified by mutagenesis\", \"In vivo cardiac phenotype of G88R not modeled in animals\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0382551\", \"supporting_discovery_ids\": [0, 4, 5, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KCNK3\"],\n    \"other_free_text\": []\n  }\n}\n```"}